Abstract
Purpose. To study the effect of probenecid on the stereoselective pharmacokinetics of oxprenolol and its glucuronides in the rabbit.
Methods. An oral dose of 50 mg/kg racemic oxprenolol was given to nine rabbits twice, in random sequence with and without the concurrent administration of probenecid. Oxprenolol enantiomers were determined in plasma and urine by an enantioselective HPLC method. Oxprenolol glucuronides were measured in plasma and urine after enzymatic hydrolysis.
Results. The disposition of the oxprenolol enantiomers in rabbits is stereoselective, mainly due to a difference in metabolism. Renal excretion is only a minor elimination route for unchanged oxprenolol, and the renal clearances of the enantiomers are similar. Pre-treatment with probenecid did not affect the plasma concentrations of the oxprenolol enantiomers, but there was a slight decrease in their urinary excretion. The plasma concentrations of the oxprenolol glucuronides are much higher than those of the parent enantiomers, and those of (S)-glucuronide are about twice those of its antipode. About 10% of the oxprenolol dose is excreted in the urine as glucuronides. The renal clearances of both glucuronides are similar, and markedly higher than the creatinine clearance. After probenecid, the mean glucuronide plasma levels were markedly higher, with for both glucuronides a more than twofold increase in mean AUC. Probenecid decreased the renal clearance of both glucuronides to about 30%. Moreover, it decreased slightly the formation clearance of (S)-glucuronide, while the formation clearance of (R)-glucuronide was not significantly influenced.
Conclusions. Our results show that in the rabbit, both oxprenolol glucuronide diastereomers are actively secreted by the kidney, and that this process is inhibited by probenecid.
Similar content being viewed by others
REFERENCES
W. Dieterle, J.W. Faigle, W. Küng and W. Theobald. The disposition and metabolism of 14C oxprenolol.HCl in man. Xenobiotica 16:181–191 (1986).
M.E. Laethem, R.A. Lefebvre, F.M. Belpaire, H.L. Vanhoe and M.G. Bogaert. Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans. Clin. Pharmacol. Ther. 57:419–424 (1995).
H.K. Kroemer and U. Klotz. Glucuronidation of drugs. A Reevaluation of the pharmacological significance of the conjugates and modulating factors. Clin. Pharmacokinet. 23:292–310 (1992).
J.O. Miners and P.I. Mackenzie. Drug glucuronidation in humans. Pharmac. Ther. 51:47–369 (1991).
G.J. Mulder. Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 32:25–49 (1992).
E. Palylyk and F. Jamali. Ketoprofen-probenecid interaction in the rat: a probenecid concentration dependent stereoselective process. J. Pharm. Sci. 82:296–300 (1993).
F.M. Belpaire, M.G. Bogaert and M. Rosseneu. Binding of β-adrenoceptor blocking drugs to human albumin, to α1-acid glycoprotein and to human serum. Eur. J. Clin. Pharmacol. 22:253–256, 1982.
F.M. Belpaire, R.A. Braeckman and M.G. Bogaert. Binding of oxprenolol and propranolol to serum albumin and α1-acid glycoprotein in man and other species. Biochem. Pharmacol. 33:2065–1069, 1984.
R.F. Cunningham, Z.H. Israili and P.G. Dayton. Clinical pharmcokinetics of probenecid. Clin. Pharmacokinet. 6:135–151 (1981).
F. Sörgel, F.E. Beyhl and E. Mutschler. Inhibition of uridine diphosphate glucuronyl transferase caused by probenecid. Experientia. 36:861–863 (1979).
T.B. Vree, M. Van dan Biggelaar-Martea and C.P.W.G.M. Verwey-Van Wissen. Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid. J. Chromatogr. 655:53–62 (1994).
Rights and permissions
About this article
Cite this article
Laethem, M.E., Belpaire, F.M., Wijnant, P. et al. Effect of Probenecid on the Enantioselective Pharmacokinetics of Oxprenolol and Its Glucuronides in the Rabbit. Pharm Res 12, 1964–1967 (1995). https://doi.org/10.1023/A:1016204309083
Issue Date:
DOI: https://doi.org/10.1023/A:1016204309083